Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 years

Recruiting
1 years - 21 years
All
Phase N/A
1 Location

Brief description of study

This randomized phase III trial is studying maintenance chemotherapy to see how well it works compared to observation following induction chemotherapy and radiation therapy in treating young patients with newly diagnosed ependymoma.

Detailed description of study

The purpose of this study is to determine the event-free survival (EFS) and overall survival (OS) of children with completely resected ependymoma treated with maintenance chemotherapy comprising vincristine sulfate, cisplatin, etoposide, and cyclophosphamide (VCEC) versus observation following post-operative conformal radiotherapy (cRT).

Participants will not be paid for their participation.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Children's Cancers,Ependymoma,Cancer,Oncology,Children,Child,Kid,Kids,Teen,Teens,Teenager,Teenagers,Youth,Adolescent,Riley,Childhood,pediatric
  • Age: 1 years - 21 years
  • Gender: All

Inclusion Criteria

Patients must be newly diagnosed with histologically confirmed intracranial ependymoma; patients with classic ependymoma (WHO II) or anaplastic ependymoma (WHO III) are eligible, as are various subtypes described as clear cell, papillary, cellular or a combination of the above

Exclusion Criteria

Patients with evidence of metastatic disease will be excluded

Patients with a diagnosis of spinal cord ependymoma, myxopapillary ependymoma, subependymoma, ependymoblastoma, or mixed glioma are NOT eligible

No prior treatment other than surgical intervention and corticosteroids; patients are allowed to have had more than one attempt at resection prior to enrollment

Pregnant female patients are not eligible for this study

Post-menarchal females may not participate unless a pregnancy test with a negative result has been obtained

Males and females of reproductive potential may not participate unless they have agreed to use an effective contraceptive method

Lactating females may not participate unless they have agreed not to breastfeed a child while on this study

Updated on 04 Aug 2024. Study ID: 1106005970 (PHO-COG-FALLON-ACNS0831)

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Zip Code
Please provide your 5-digit zip code
0 0 /250
Other language

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team